Praxis Precision Medicines, Inc. (PRAX:NASDAQ) closed at $239.02 on October 14, 2026, down 1.78% on the day. The stock trades 39.1% below its 52-week high of $392.70 and 354.2% above its 52-week low of $52.62. Over the past year, it gained 316.8%. Praxis Precision Medicines, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -4.92% | -23.61% | -23.98% | -30.23% | +316.77% |
In 252 trading sessions since October 14, 2025, PRAX closed higher on 120 days (48%). Its best day was October 16, 2025 (+183.71%) and its worst was June 2, 2026 (-23.00%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 4 times.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in developing therapies for patients and families affected by complex and debilitating brain disorders. The firm's pipeline covers PRAX-114, PRAX-944, PRAX-562, and PRAX-222 among others.
Find more stocks like PRAX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.